These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8522262)

  • 1. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor).
    Kadar N; Krumerman M
    Gynecol Oncol; 1995 Dec; 59(3):394-7. PubMed ID: 8522262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature.
    Chamberlin MD; Eltabbakh GH; Mount SL; Leavitt BJ
    Gynecol Oncol; 2001 Jul; 82(1):212-5. PubMed ID: 11426990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
    Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
    Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
    Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
    Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 May; 30(5):614-24. PubMed ID: 16699316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endosalpingiosis of the axillary lymph nodes--primary or metastatic tumour?].
    Stolnicu S; Mocan S; Coros MF; Rădulescu D; Bara T
    Chirurgia (Bucur); 2005; 100(3):297-300. PubMed ID: 16106940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic spread among women with primary peritoneal carcinoma.
    Eltabbakh GH; Mount SL
    J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ovarian tumors of low malignant potential: an intra- and retroperitoneal disease?].
    Maassen V
    Geburtshilfe Frauenheilkd; 1993 Mar; 53(3):163-8. PubMed ID: 8385641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benign epithelial inclusions in pelvic lymph nodes. 2 case reports].
    Alvarado Cabrero I; Sosa Romero A
    Ginecol Obstet Mex; 2000 Feb; 68():77-81. PubMed ID: 10774109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer.
    Pereira A; Magrina JF; Rey V; Cortes M; Magtibay PM
    Gynecol Oncol; 2007 Jun; 105(3):604-8. PubMed ID: 17321572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors for retroperitoneal lymph node metastasis in ovarian cancer].
    Akiyama M; Takahashi Y; Hirose M; Yamamoto Y; Ishiguro T; Noda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Mar; 46(3):260-4. PubMed ID: 8133137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
    Roger N; Zafrani Y; Uzan C; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
    Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Müllerian and mesothelial lymph node involvement in patients with borderline ovarian tumors.
    Eltabbakh GH; Mount SL
    J Reprod Med; 2011; 56(5-6):211-8. PubMed ID: 21682116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal endosalpingiosis in ovarian serous tumors of low malignant potential with lymph node involvement: a case for a precursor lesion.
    Djordjevic B; Clement-Kruzel S; Atkinson NE; Malpica A
    Am J Surg Pathol; 2010 Oct; 34(10):1442-8. PubMed ID: 20871218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperplastic mesothelial cells within abdominal lymph nodes: mimic of metastatic ovarian carcinoma and serous borderline tumor--a report of two cases associated with ovarian neoplasms.
    Clement PB; Young RH; Oliva E; Sumner HW; Scully RE
    Mod Pathol; 1996 Sep; 9(9):879-86. PubMed ID: 8878019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma.
    Dubernard G; Morice P; Rey A; Camatte S; Pautier P; Lhommé C; Duvillard P; Castaigne D
    Gynecol Oncol; 2005 Apr; 97(1):136-41. PubMed ID: 15790449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors).
    Fadare O
    Int J Gynecol Cancer; 2009 Jan; 19(1):103-8. PubMed ID: 19258950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.